Literature DB >> 7049503

Diphenhydramine: kinetics and psychomotor effects in elderly women.

W G Berlinger, M J Goldberg, R Spector, C K Chiang, M Ghoneim.   

Abstract

Kinetics and sedative and psychomotor effects of diphenhydramine were investigated in elderly Caucasian women (greater than 64 yr. old). In a double-blind trial, each of 12 healthy subjects received on one of three occasions 50 mg/70 kg IV or oral diphenhydramine HCl or oral placebo. Plasma levels of diphenhydramine were measured in six subjects and tests of sedation and psychomotor performance were performed hourly for 8 hr in all subjects. Kinetic analysis showed that the volume of distribution (295 +/- 50 [SEM] l/70 kg), clearance (42 +/- 5 l/70 kg/hr), and plasma t1/2 (4.9 +/- 0.7 hr) were of the same order as in young adults. As in young adults, there was minimal psychomotor impairment after oral and after intravenous diphenhydramine. In contrast to young adults, however, elderly women did not report significant sedation after diphenhydramine. These results suggest that diphenhydramine may not be an effective sedative/hypnotic in elderly women.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7049503     DOI: 10.1038/clpt.1982.176

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  4 in total

Review 1.  Hepatic drug metabolism and aging.

Authors:  C Durnas; C M Loi; B J Cusack
Journal:  Clin Pharmacokinet       Date:  1990-11       Impact factor: 6.447

Review 2.  Clinical pharmacokinetics of H1-receptor antagonists (the antihistamines).

Authors:  D M Paton; D R Webster
Journal:  Clin Pharmacokinet       Date:  1985 Nov-Dec       Impact factor: 6.447

Review 3.  Identification of populations at risk in drug testing and therapy: application to elderly patients.

Authors:  W A Ritschel
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1993 Jan-Mar       Impact factor: 2.441

4.  A pharmacokinetic evaluation of five H(1) antagonists after an oral and intravenous microdose to human subjects.

Authors:  Ajay Madan; Zhihong O'Brien; Jianyun Wen; Chris O'Brien; Robert H Farber; Graham Beaton; Paul Crowe; Berend Oosterhuis; R Colin Garner; Graham Lappin; Haig P Bozigian
Journal:  Br J Clin Pharmacol       Date:  2009-03       Impact factor: 4.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.